‘A Tough Call’: Biden Considering Mandatory COVID Vaccines for U.S. Troops
President Joe Biden said he has not ruled out requiring all U.S. troops to get the coronavirus vaccine after the shots win final clearance from federal regulators, but cautioned that such a decision would be a “tough call.”
“I don’t know. I’m going to leave that to the military,” Biden told NBC News’ Craig Melvin in an interview that aired Friday, in response to a question on whether he would mandate the vaccine for U.S. service members once it is fully approved by the Food and Drug Administration.
Significant Jump in Reported Injuries, Deaths After COVID Vaccine Compared to Last Week
Data released today by the Centers for Disease Control and Prevention (CDC) on the number of injuries and deaths reported to the Vaccine Adverse Event Reporting System (VAERS) following COVID vaccines showed a significant jump in reports of injuries and deaths compared with last week’s numbers.
… Every Friday, VAERS makes public all vaccine injury reports received as of a specified date, usually about a week prior to the release date. Today’s data show that between Dec. 14, 2020 and April 23, a total of 118,902 total adverse eventswere reported to VAERS, including 3,544 deaths — an increase of 358 over the previous week — and 12,619 serious injuries, up 2,467 since last week.
3 Reasons Miami School Might Be Right About Asking Teachers Not to Get COVID Vaccine
Centner Academy, a private school in Miami, has made international headlines for directing its employees who have not yet received the experimental COVID-19 vaccine, to wait until the end of the school year, as a precautionary step to protect the health of their school community, given both concerning new anecdotal reports that the vaccinated can adversely affect the health of the un-vaccinated, and that clinical safety and efficacy data for the mRNA vaccines will not be completed until sometime in 2023.
Thus far, mainstream media reporting has focused and railed against the following statement made by Leila Centner, co-founder and CEO of Centner Academy, to her employees (in an internal email later leaked to the press) as being the most controversial and contestable:
“Tens of thousands of women all over the world have recently been reporting adverse reproductive issues simply from being in close proximity with those who have received any one of the COVID-19 injections, e.g., irregular menses, bleeding, miscarriages, post-menopausal hemorrhaging and amenorrhea (complete loss of menstruation)…”
Pfizer, BioNtech Seek EU’s Ok to Use COVID Vaccine on Kids
Pfizer Inc. and BioNTech have submitted a request to the European drug regulator for the approval of their coronavirus vaccine to be extended to include children 12 to 15 years old, in a move that could offer younger and less at-risk populations in Europe access to the shot for the first time.
In a statement Friday, the two pharmaceuticals said their submission to the European Medicines Agency is based on an advanced study in more than 2,000 adolescents that showed their vaccine to be safe and effective. The children will continue to be monitored for longer-term protection and safety for another two years.
In Wake of Emergent Biosolutions’ Vaccine Problems, CEO’s Stock Trades Come Into Focus
Standing alongside Maryland Gov. Larry Hogan at their Baltimore-area plant, Emergent CEO Robert Kramer boasted about the biotech firm’s role as “one of the key suppliers” helping to produce two promising COVID-19 vaccines, and its “valuable contribution to society in being able to make hundreds of millions of doses available.”
… What investors say they were not told: Emergent had at that time discarded vaccine ingredients slated for millions of Johnson & Johnson doses due to a string of quality control errors. And that on Feb. 8, nearly six weeks before Emergent’s lab errors became public, Kramer had completed a weeks-long stock transaction that netted him millions of dollars — and that later saved him millions more when the company’s stock tumbled upon news of its failures, securities filings show.
AstraZeneca Struggles With Data Needed for COVID-19 Vaccine’s Approval
AstraZeneca PLC executives have struggled to pull together the full data necessary to apply for U.S. approval of its COVID-19 shot, according to people familiar with the matter, further delaying its efforts to secure the Food and Drug Administration’s go-ahead.
The company said last month that it would apply for what is known as emergency use authorization for its vaccine by mid-April. It has recently told U.S. officials it might need until mid-May to finish its application for an FDA review, according to one of these people.
Inovio Sinks 26% After U.S. Government Decides to Discontinue Funding for Next Phase of COVID-19 Vaccine Trial
The biotech company said it was informed that it will lose federal financial support for the phase three segment of its Innovate trial for INO-4800. The DNA vaccine candidate is aimed at preventing infection from SARS-CoV-2, the coronavirus behind the COVID-19 disease.
“The decision results from the changing environment of COVID-19 with the rapid deployment of vaccines,” said Inovio in a statement. “This decision is not a reflection of the awardee or product, rather a fast-moving environment associated with the former Operation Warp Speed on decisions related to future products.”
Joe Rogan Clarified His Controversial Comments About the COVID-19 Vaccine
After facing a backlash that reached all the way to Dr. Anthony Fauci, podcaster Joe Rogan has tried to clarify his recent comments about the COVID-19 vaccine. Unfortunately, he hasn’t cleared up much other than, as he puts it, “I’m not a respected source of information — even for me.”
The controversy began when, on a recent episode of The Joe Rogan Experience, Rogan said that while he believes the vaccine is safe, he doesn’t think young, healthy people need it. “If you’re like 21 years old, and you say to me, ‘Should I get vaccinated?’ I’ll go, ‘No,’” he said.
AstraZeneca COVID Vaccine Sales Hit $275 MN in First Quarter
British pharmaceuticals giant AstraZeneca said Friday that its COVID vaccine generated $275 million (227 million euros) in sales in the first quarter, as its chief executive defended the company’s performance in the face of EU legal action.
This is the first time that the company has disclosed figures from sales of one of the world’s leading vaccines, which it sells on a not-for-profit basis.
However, public confidence in the jab has been dented over links to very rare blood clots, and the company is also mired in a legal fight with the EU over delivery shortfalls.
The Latest: India Sets Record of 386,000 Daily Virus Cases
India has set another global record with 386,452 daily coronavirus cases.
The Health Ministry on Friday also reported 3,498 deaths in the last 24 hours, bringing the total to 208,330. Experts believe both figures are an undercount, but it’s unclear by how much.
India’s pandemic response has been marred by insufficient data. An online appeal — signed by over 350 scientists Friday afternoon — asks the government to release data about the sequencing of virus variants, testing, recovered patients and how people were responding to vaccines.
The post Biden Considering Mandatory COVID Vaccines for U.S. Troops + More appeared first on Children’s Health Defense.